Crystal Structures of β-Neurexin 1 and β-Neurexin 2 Ectodomains and Dynamics of Splice Insertion Sequence 4  by Koehnke, Jesko et al.
Structure
ArticleCrystal Structures of b-Neurexin 1 and
b-Neurexin 2 Ectodomains and Dynamics
of Splice Insertion Sequence 4
Jesko Koehnke,1 Xiangshu Jin,1 Nikola Trbovic,1 Phinikoula S. Katsamba,1,2 Julia Brasch,1 Goran Ahlsen,1
Peter Scheiffele,3 Barry Honig,1,2 Arthur G. Palmer III,1 and Lawrence Shapiro1,4,*
1Department of Biochemistry and Molecular Biophysics
2Howard Hughes Medical Institute
3Department of Physiology and Cellular Biophysics and Department of Neuroscience
4Edward S. Harkness Eye Institute
Columbia University, 630 West 168th Street, New York, NY 10032, USA
*Correspondence: lss8@columbia.edu
DOI 10.1016/j.str.2007.12.024SUMMARY
Presynaptic neurexins (NRXs) bind to postsynaptic
neuroligins (NLs) to formCa2+-dependent complexes
that bridge neural synapses. b-NRXs bind NLs
through their LNS domains, which contain a single
site of alternative splicing (splice site 4) giving rise
to two isoforms: +4 and D. We present crystal struc-
tures of the D isoforms of the LNS domains from
b-NRX1 and b-NRX2, crystallized in the presence of
Ca2+ ions. The Ca2+-binding site is disordered in the
b-NRX2 structure, but the 1.7 A˚ b-NRX1 structure re-
veals a singleCa2+ ion,12 A˚ from the splice insertion
site, with one coordinating ligand donated by a gluta-
mic acid from an adjacent b-NRX1 molecule. NMR
studies of b-NRX1+4 show that the insertion se-
quence is unstructured, and remains at least partially
disordered in complex with NL. These results raise
the possibility that b-NRX insertion sequence 4 may
function in roles independent of neuroligin binding.
INTRODUCTION
Neurexins (NRXs) and neuroligins (NLs) are implicated as central
organizing molecules for excitatory glutamatergic and inhibitory
GABAergic synapses in the vertebrate nervous system (Brose,
1999; Chih et al., 2005; Dean and Dresbach, 2006; Graf et al.,
2004). They function as cell adhesion molecules, with postsyn-
aptic neuroligins binding to presynaptic neurexins to form trans-
synaptic complexes (Missler et al., 1998). Members of each pro-
tein family can trigger formation of a hemisynapse: neuroligins
trigger presynaptic differentiation (Scheiffele et al., 2000) and
neurexins trigger postsynaptic differentiation (Graf et al., 2004).
Interference with the neurexin/neuroligin system leads to defects
in synaptic transmission (Chih et al., 2005; Missler et al., 2003;
Varoqueaux et al., 2006), and human genetic studies have iden-
tified neuroligin genes as strong candidates for a causative role
in autism spectrum disorders (Garber, 2007; Jamain et al.,
2003; Tabuchi et al., 2007).410 Structure 16, 410–421, March 2008 ª2008 Elsevier Ltd All rightNeurexins and neuroligins are diversified by alternative mes-
senger RNA splicing such that up to four variant mature proteins
are produced for each neuroligin gene, and up to thousands are
produced for each neurexin gene. The neurexin family includes
three members in mammals, NRX1-3 (Ichtchenko et al., 1996).
Each family member is encoded by a gene that includes two in-
dependent promoters, which are either used to express a long
a-NRX, or a truncated b-NRX with a unique N terminus (Figure 1)
(Ushkaryov and Sudhof, 1993). Both forms undergo alternative
splicing at five different sites (sites 1-5) in a-NRX and two sites
(sites 4 and 5) in b-NRX (Ichtchenko et al., 1996; Tabuchi and
Sudhof, 2002; Ushkaryov and Sudhof, 1993).
Neuroligins, the postsynaptic binding partners of neurexins,
are also diversified by alternative splicing. Five members of the
NL family are known in humans (Bolliger et al., 2001; Ichtchenko
et al., 1995; Ichtchenko et al., 1996; Jamain et al., 2003), and at
least four genes have been discovered in rodents: Nlgns 1-3
(Varoqueaux et al., 2006) and the more distant member Nlgn6
(GenBank accession number: EF692521). Two potential sites of
alternative splicing, A and B, are found in the Nlgn genes. Nlgn3
has two alternative exons that can be inserted at site A; the B
splice insertion site is only used inNlgn1. This gives rise to a total
of 10 different isoforms forNlgn1-3 (four forNlgn1, two forNlgn2,
and four for Nlgn3). Neuroligin subtypes are differentially local-
ized in vivo: NL1 is found predominantly at excitatory synapses,
NL2 at inhibitory synapses, and NL3 at both. (Budreck and
Scheiffele, 2007; Song et al., 1999; Varoqueaux et al., 2004).
Recent protein interaction and cell culture studies indicate that
alternative splicing also confers functional properties for both
neurexins and neuroligins; for example, an insert at splice site 4
ofb-NRXs selectively promotesGABAergic postsynaptic assem-
bly (Chih et al., 2006; Graf et al., 2006), whereas an insert at site B
of NL1 promotes selective function at glutamatergic synapses
(Chih et al., 2006). These findings and the considerablemolecular
diversity of NLs andNRXs and the differential effects of some iso-
forms has led to the hypothesis that alternative splicing in NRXs
and NLs might underlie a selective adhesive code for CNS
synapses.
Initial insights into the structural basis of b-NRX/NL interaction
have been acquired through solution small angle X-ray scatter-
ing experiments (Comoletti et al., 2007). This study yields insights reserved
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Structures of b-NRX1 and b-NRX2Figure 1. The a- and b-Neurexins Are
Transcribed from Alternative Promoters of
the Same Genes
a-Neurexins contain an N-terminal signal peptide,
which is removed from the mature protein fol-
lowed by neurexin repeats, consisting of LNS
(green) and EGF-like domains (blue). a- and
b-NRX share a common transmembrane segment
and short cytoplasmic region. The b-neurexins
contain a different signal peptide and a short
b-neurexin-specific sequenceand sharemembrane
proximal regions, including the final LNS domain,
LNS6, with their a counterparts. Positions of the
five alternative splice sites of a-neurexins are num-
bered and indicated by arrows.into the overall shape of the complex, and shows that neuroligins
likely dimerize via a four-helix bundle motif characteristic of the
related cholinesterases. One b-NRX molecule binds to each NL
protomer to form a 2:2 complex, with the two b-NRX molecules
separated by 107 A˚. Nevertheless, atomic-level mechanisms
of b-NRX/NL interactions remain unclear.
The neuroligin-binding region of b-neurexin ectodomains is
composed of a single laminin-neurexin-sex (LNS) hormone do-
main. Two LNS domain crystal structures from neurexins have
been previously determined. The first of these (Rudenko et al.,
1999), corresponding to the neuroligin-binding b-NRX1 LNS do-
main frommouse, revealed a structure similar to that of agrin, an-
other LNS domain-containing protein. Agrin is also alternatively
spliced, and the positions of alternative splice sites are con-
served between agrin and b-NRX1 (Rudenko et al., 1999).
Alternative splicing of agrin is thought to play a regulatory role
in the organization of neuromuscular junctions (Ferns et al.,
1993). A recent functional mutagenesis study has confirmed
that binding to neuroligins and synaptogenic activity is mediated
by the same face of the b-NRX1 LNS domain that contains the
alternative splice sites (Graf et al., 2006).
The other LNS-domain crystal structure known for neurexins is
that of the second LNS domain of a-NRX1, which is not known to
interact with neuroligins. This structure revealed a Ca2+ ion
bound near the positions of the alternative splice sites (Sheckler
et al., 2006). BoundCa2+was not found in the original structure of
b-NRX1; however, the crystallization conditions were devoid of
calcium. Sequence analysis reveals conservation of the Ca2+
ligating residues, suggesting that b-neurexins may also bind
calcium at this position. Mutation of two of these putative cal-
cium binding residues was found to ablate neuroligin interaction
(Graf et al., 2006). Neurexins have three known extracellular
binding partners in the mammalian brain: neuroligins, dystrogly-
can, and neurexophilins (Ichtchenko et al., 1995; Petrenko et al.,
1996; Sugita et al., 2001). Neuroligins exhibit Ca2+-dependent
binding to a- and b-neurexins, dystroglycan shows Ca2+-depen-
dent binding preferentially to a-neurexins, and neurexophilin
binding is Ca2+-independent and specific to a-neurexin.
We report crystal structures for the D splice forms of the mem-
brane-proximal neuroligin-binding LNS domains from b-NRX1
and b-NRX2, determined in the presence of Ca2+ ions. The 1.7 A˚
resolution structure from b-NRX1 reveals a bound Ca2+ ion, li-
gated by side chains from residues D137 and N208, and car-Structurebonyl oxygen atoms fromV154 and I206, corresponding to a sim-
ilar Ca2+ binding site identified in structures of another LNS
domain. The structure presented shows that the Ca2+ ion is in-
completely coordinated by the b-NRX1 molecule, and coordina-
tion is completed by a glutamic acid side chain fromanothermol-
ecule. This is similar to findings for the ligand-binding A domains
from integrins, which contain a metal ion-dependent adhesion
site (MIDAS) organized around an incompletely coordinated
Mg2+ ion (Lee et al., 1995). The Ca2+ binding site of the b-neu-
rexin ectodomain involves elements of the b9-b10 loop that
also contains splice insertion 4. This region of the molecule is
disordered in the 3.0 A˚ b-NRX2 structure, indicating substantial
molecular mobility in the neuroligin-binding region. Nuclear
magnetic resonance (NMR) chemical shifts and nuclear Over-
hauser effect measurements for the D and +4 splice forms of
b-NRX1 suggest that the peptide segment inserted at splice in-
sertion 4 is disordered both in the absence of neurexin-binding
partners and in the presence of at least one binding partner,
neuroligin. The apparent lack of participitation of the splice inser-
tion sequence in binding to neuroligins suggests that b-NRX
insertion sequences might play roles independent of neuroligin
binding.
RESULTS
Production of Recombinant Neurexins
and Crystallization
We focused on the single LNS domain of the b-neurexins ecto-
domain segment, which contains the neuroligin-binding site of
b-neurexins, as well as a single site of alternative splicing, splice
insertion site 4. We thus produced each of the neurexins in two
splice forms: one that included splice insertion sequence 4 (re-
ferred to as +4), and another lacking this insertion (referred to
as D). Extracellular domains of b-NRX were expressed as GST-
fusion proteins in Escherichia coli. We used a Mosquito crystal-
lization robot to screen through commercially prepared sets of
crystallization reagents and found crystallization ‘‘hits’’ for each
of the neurexins lacking splice insertion sequences: b-NRX1D,
b-NRX2D, and b-NRX3D. Crystals of b-NRX1D and b-NRX2D
were optimized, and we present structures at 1.7 A˚ and 3.0 A˚
resolution for b-NRX1D and b-NRX2D, respectively. Despite
extensive screening (at least 1000 conditions for each protein16, 410–421, March 2008 ª2008 Elsevier Ltd All rights reserved 411
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Structures of b-NRX1 and b-NRX2at both 4C and 20C), no crystals could be obtained for any of
the neurexins that included a splice insertion sequence.
Biophysical Analysis of Neurexins
and Complexes with Neuroligins
In order to determine the oligomeric states of the neurexins and
neuroligins used in our studies, and to characterize their associ-
ation as complexes, we used multiple methods of biophysical
analysis. First, equilibrium analytical ultracentrifugation (AUC)
was used to characterize the association states of the LNS
regions from b-NRX1D, b-NRX1+4, and b-NRX2D. The solubility
Figure 2. Binding Analysis of b-NRX1D and
1+4 with NL1A and NL2A
(A–C) Sedimentation velocity analysis of
b-NRX1+4, NL1A, and their complex. SPR senso-
grams of the interactions of b-NRX1D and
b-NRX1+4 with immobilized NL1A (B) and NL2A
(C). Binding was tested at the concentration range
indicated in each panel.
(D) Binding isotherms for b-NRX1D (shown in red)
and 1+4 (shown in blue) interacting NL1A and 2A.
The responses versus concentration plots were fit
using a 1:1 interaction model. The KD for each in-
teraction is listed in Table 1. The two plots are
drawn to scale.
of the b-NRX2+4 protein was too low
for accurate AUC determinations, yield-
ing precipitate in later stages of the
run. The results of these experiments
(data not shown) show that the LNS do-
mains from b-NRX1D, b-NRX1+4, and
b-NRX2D all behave as monomers and
reveal no evidence of higher-order asso-
ciations. These results agree with earlier
AUC experiments on neurexins (Como-
letti et al., 2006). Second, we produced
b-NRX1/NL1A ectodomain complexes
by incubating a slight molar excess of ei-
ther b-NRX1D or b-NRX1+4 ectodomains
with the soluble ectodomain from NL1A,
and separated complexes from unbound
b-NRX1 by gel filtration chromatography.
In these experiments, using a calibrated
Superdex S200 column, b-NRX/NL com-
plexes eluted at a volume corresponding
to molecular mass190 kDa, suggesting
a 2:2 complex. Sedimentation velocity
experiments on an isolated b-NRX1+4/
NL1A complex (Figure 2A) yielded a sedi-
mentation coefficient of 7.3 s, consis-
tent with a 2:2 b-NRX/NL complex as re-
ported previously (Comoletti et al., 2006).
Splice Insertion Sequence 4
Weakens b-NRX1 Interactions
with NL1A and NL2A
Surface plasmon resonance (SPR) bind-
ing assays were used to determine the
effect of the insert at splice site 4 of b-NRX1 in b-NRX1/NL inter-
actions (Figures 2B–2D and Table 1). Purified neuroligins were
tethered to the chip surface. This experimental configuration
avoids the avidity effects that would result from using the dimeric
neuroligins as the mobile analyte. Avidity enhancement by ana-
lyte multimerism can contribute to substantial artificial enhance-
ment of measured KDs (Myszka, 1999). Preliminary binding tests
revealed that b-NRX1D and especially b-NRX1+4 injected at
2 and 4 mM, respectively, bound nonspecifically to the dextran
layer of the sensor chip. Addition of BSA in the running buffer
was sufficient to suppress such nonspecific interactions.412 Structure 16, 410–421, March 2008 ª2008 Elsevier Ltd All rights reserved
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Structures of b-NRX1 and b-NRX2Figure 2B shows high-quality sensograms for the interaction of
b-NRX1D and b-NRX1+4 with NL1A. The triplicate injections for
each concentration were highly reproducible, indicating that
b-NRX1D and b-NRX1+4 binding to NL1A was specific. The bind-
ing reactions reached equilibrium at all concentrations tested. The
responses at equilibriumwere plotted against the concentration of
neurexin to calculate theKD for each interaction using a 1:1 binding
model (Figure 2D). The b-NRX1D/NL1A interaction had a KD of
206.9(8) nM compared with the b-NRX1+4/NL1A interaction,
which had a KD of 571(2) nM. (The number in parentheses for all
KDs represents the error of the fit in the last significant digit.)
Thus, the presence of the insert at splice site 4 of b-NRX1weakens
binding almost three-fold.
To investigate whether the change in affinity in the presence of
the insert at splice site 4 of b-NRX1 is isoform specific, the inter-
actions of b-NRX1D and +4 were also examined with NL2A
(Figure 2C). The sensograms exhibit the same general behavior
as with NL1A, with highly reproducible responses that reach
equilibrium at all concentrations tested. From the equilibrium-
binding analysis in Figure 2D, the KD for the b-NRX1D/NL2A in-
teraction was 238.3 (7) nM, while the KD for the b-NRX1+4/
NL2Awas 621.2 (8) nM. Just as we found for NL1A, the presence
of the insert at splice site 4 of b-NRX1weakened binding approx-
imately 2.6-fold, suggesting that the presence of splice insertion
4 causes a moderate decrease in neuroligin binding affinity. A
previous study reported that the presence of splice insert 4 re-
duced the relative affinity of b-NRX1 for NL1A by 2.1-fold but en-
hanced the relative affinity of b-NRX1 for NL2A (Comoletti et al.,
2006). This study was also based on SPR binding assays; how-
ever, the limited quality of the SPR data prevented the authors
from calculating the absolute affinities for these interactions. Es-
timation of relative KDs from such ‘‘comparative’’ SPR analyses
is known to be unreliable (van Holde et al., 2005).
NMR Experiments Reveal that Splice Insertions
at b-Neurexin Splice Site 4 Are Disordered,
Even in Neuroligin Complexes
Our inability to obtain crystals of neurexins that include splice in-
sertion sequences suggested that the insertions might be struc-
turally disordered, thereby hampering crystallization. We there-
fore performed solution NMR experiments using 15N-labeled
neurexins 1D and 1+4 that were identical but for the presence
of the splice insertion sequence.
First, we recorded fast heteronuclear single quantum coher-
ence (FHSQC) 1H-15N spectra to assess the foldedness and
uniqueness of the conformations of b-NRX1D and b-NRX1+4.
Second, we measured the steady-state {1H}-15N nuclear Over-
Table 1. KDs for the Interaction of b-NRX1D and 1+4 with NL1A
and 2A
NL b-NRX KD (nM)
KD Ratio Relative
to D Isoform
1A 1D 206.9 (8) 1
1 + 4 571 (2) 2.8
2A 1D 238.3 (7) 1
1 + 4 621.2 (8) 2.6
Values in parentheses represent the error of the fit in the last significant
digit.Structure 1hauser effect (NOE) to establish the degree of conformational re-
striction of the polypeptide backbone. Because the amide N-H
bond has an essentially fixed length, the steady-state NOE
depends only on the motion of each peptide moiety and typically
is >0.5 for well-ordered sites in globular proteins.
FHSQC spectra for b-NRX1D and b-NRX1+4 are shown in Fig-
ure 3. In Figures 3A and 3B, the crosspeaks have been color-
coded to indicate whether the peaks are common to both spec-
tra, unique to b-NRX1D, or unique to b-NRX1+4. In Figures 3C
and 3D, the crosspeaks have been color-coded to indicate
whether the {1H}-15N NOE is less than or greater than 0.5 (a value
distinguishing relatively ordered from relatively disordered sites).
The FHSQC spectrum of b-NRX1D contains 214 backbone
crosspeaks, more than the expected number of 166 based on
the protein sequence. Gel filtration chromatography, native gel
electrophoresis, and mass spectrometry indicate that the
b-NRX1D sample is chemically homogeneous (data not shown),
strongly suggesting a dynamic interchange between two confor-
mations in equilibrium. A 15N ZZ-exchange experiment (Farrow
et al., 1994b) with amixing time of 1 s did not show any exchange
crosspeaks, demonstrating that the kinetic rate constants for ex-
change between conformations is <1 s1 (data not shown). Of
214 crosspeaks, 148 crosspeaks could be associated with
crosspeaks in the spectrum of b-NRX1+4, and 49 crosspeaks
were unique to the b-NRX1D spectrum. The 49 unique peaks
had a lower average intensity (34%) compared with the remain-
der of the crosspeaks but had similar NOEs (0.77 versus 0.78)
and 1H resonance linewidths (21.5 s1 for both). These results
suggest that the resonances in common between b-NRX1D
and b-NRX1+4 represent a major species present in the sample
of b-NRX1D with a similar conformation as b-NRX1+4. Further-
more, the unique set of resonances reflect a minor species
with dynamic properties similar to the major species, which is
therefore also likely to be a globular conformational state.
The FHSQCspectrum for b-NRX1+4 contains 181 crosspeaks;
148 of these, as noted above, are associated with corresponding
major peaks in the b-NRX1D spectrum. Few crosspeaks in the
spectrum of b-NRX1+4 are associated with the resonance shifts
of the minor form of b-NRX1D. Instead, a total of 24 crosspeaks
unique to the b-NRX1+4 spectrum appear mostly at the reso-
nance frequencies expected for a disordered random peptide
chain. Furthermore, one of these unique crosspeaks is found in
the region of the spectrum characteristic of Trp side chain indole
15N31-1H31 resonances, likely corresponding to the indole of
Trp226 in the splice insertion. The majority (20/24) of the unique
peaks, including the putative indole of Trp226, have NOEs <0.5
comparedwith an average of 0.70. Thesedata suggest that inclu-
sion of the splice insertion sequence shifts the conformational
equilibrium that leads to supernumerary peaks for b-NRX1D to
favor the major species, and that the splice insertion itself gives
rise to the group of peaks, not present in the D isoform, which
appear to be disordered.
Taken together, these data strongly imply that (1) the major
species of b-NRX1D and b-NRX1+4 have similar structures; (2)
a minor species is populated in b-NRX1D, but not b-NRX1+4;
and (3) in the absence of a binding partner, the splice insertion
sequences of b-neurexins are disordered. The very slow confor-
mational equilibrium observed in b-NRX1D may reflect slow-
timescale dynamics of the long b9-b10 loop that contains the6, 410–421, March 2008 ª2008 Elsevier Ltd All rights reserved 413
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Structures of b-NRX1 and b-NRX2Figure 3. FHSQC Spectra of b-NRX1D and
b-NRX1+4
Dashed boxes indicate aliased resonances from
arginine N3-H3 groups.
(A and B) Resonances common to the spectra of
(A) b-NRX1D and (B) b-NRX1+4 are shown in
black, and resonances new to either spectrum
are shown in red. Resonances that could not be
clearly assigned to either of these categories are
shown in green.
(C and D) Resonances of (C) b-NRX1D and (D)
b-NRX1+4 spectra with a heteronuclear {1H}-15N
NOE value <0.5 are shown in red; values >0.5
are shown in black.
The final structure, refined at 1.7 A˚ resolu-
tion (R = 0.176, Rfree = 0.220) had one
molecule per asymmetric unit, 1481 pro-
tein atoms, 188 water molecules, and
one Ca2+ ion bound per neurexin proto-
mer. Using this structure as a search
model, we determined the structure of
b-NRX2D at 3.0 A˚ resolution (R = 0.211,
Rfree = 0.289). (Because of the limited res-
olution, this model included no water
molecules.) In contrast with the
b-NRX1D structure, in b-NRX2D the Ca2+
binding region is disordered, and no elec-
tron density is seen for a calcium ion or the
expected calcium binding ligands (Fig-
ure 5).splice insertion site. Insertion of 30 additional residues into this
loop might be responsible for shifting the equilibrium toward
the major conformation. The position of the splice insertion into
a long loop combined with the flexibility of the splice insertion
found by NMR likely explains our inability to produce crystals
of lone neurexins containing these sequences.
An FHSQC spectrum also was recorded for a complex be-
tween [U-99% 15N]-b-NRX1+4 and unlabeled NL1A (NL1 con-
taining splice insertion A). The complex is 2:2 b-NRX1+4/NL1A
with a total molecular mass of 190 kDa. As shown in Figure 4,
resonances for well-ordered amide groups are nearly completely
absent from the spectrum owing to fast transverse relaxation. In
contrast, a set of resonances is observed at resonance frequen-
cies corresponding to amide groups with NOEs <0.5 in the free
b-NRX1+4 protein, most of which are unique to b-NRX1+4. Ob-
servation of these resonances suggests that the splice insertion
in b-NRX1+4 remains largely disordered in the complex with
NL1A. Importantly, the putative Trp226 indole resonance also
is observed in the spectrum of the complex (Figure 4B); the large
hydrophobic side chain of Trp226 would be expected to be part
of an intermolecular interface, and consequently well ordered, if
the splice insertion sequence contributed significantly to binding
between b-NRX1+4 and NL1A.
Structures of b-Neurexin 2D and b-Neurexin
1D Ca2+ Complex
The b-NRX1D structure was determined by molecular replace-
ment using PDB structure 1C4R as a search model (Table 2).414 Structure 16, 410–421, March 2008 ª2008 Elsevier Ltd All righThe neurexins adopt an all-b topology related to that of many
lectins. The 1.7 A˚ structure of b-NRX1D reveals clear electron
density for the Ca2+ ion and its protein ligands (Figure 6A).
Ca2+ is ligated by residues in multiple loops at the membrane-
distal end of the neurexin ectodomain, including side chain oxy-
gen atoms of Asn 208 and Asp137, and backbone carbonyl
groups from Val 154 and Ile 206, and is additionally coordinated
by the side chain of Glu 219 from a symmetry-related protomer.
Site-directed mutation of both residues whose side chains are
involved in calcium binding, Asn 208 and Asp137, result in loss
of NL binding (Graf et al., 2006), indicating that metal coordina-
tion in the LNS domain plays an important role in molecular
recognition. The b-NRX1D structure reported here reveals an
‘‘extra’’ Ca2+ coordination position that is fortuitously occupied
by a Glu side chain. This suggests the possibility that binding
of NLs may exploit the b-NRX Ca2+ site in a similar way.
Splice insertion 4 of b-NRX1 is at position 200 (magenta
sphere in Figure 5 and 6B), where the 30 residue insertion se-
quence is located in b-NRX1+4. This site is only 12.4 A˚ from
the bound Ca2+ ion measured from the Ca of Arg 200 in the
b-NRX1D structure. Thus both the Ca2+ binding site implicated
in direct neuroligin interactions and the splice insertion site
appear to compose parts of a localized site that could provide a
diversified surface for ligand interaction.
The structure of b-NRX2D was determined from crystals
grown in conditions that include Ca2+ ions; however, no density
is observed for a Ca2+ ion or for the b9-b10 loop of the Ca2+ bind-
ing region. The apparent mobility of this region in b-NRX2 raisests reserved
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Structures of b-NRX1 and b-NRX2the possibility that the well-ordered structure observed for
b-NRX1 might arise from the fortuitous ligation of the bound Ca2+
ion by a side chain from a crystal mate. However, it also remains
possible that the low pH of these crystals (pH 4.9) impaired Ca2+
binding, which could also underlie the observed lack of defined
structure. The disordered region of the b-NRX2 b9-b10 loop also
includes residue 200, the position of splice insertion site 4. The
possibility that this region is mobile agrees with the NMR data pre-
sented above. First, supernumerary crosspeaks in the FHSQC
fingerprint region of b-NRX1D could indicate exchange between
conformational isomers. Second, this conformational exchange
likely takes place in regions near splice site 4, because inclusion
of a splice insertion at this position collapses the spectrum to
that of an apparent single molecular species.
Figure 4. Overlay of the FHSQC Spectrum of [U-99% 15N]-b-NRX1+4
in Complex with Unlabeled NL1A (green) with the FHSQC Spectrum
of [U-99% 15N]-b-NRX1+4 Alone
(A) In the FHSQC spectrum of the uncomplexed b-NRX1+4, resonances not
observed for b-NRX1D are shown in red; all remaining resonances are shown
in black. Dashed boxes (black for the spectrum of the uncomplexed
b-NRX1+4, green for the spectrum of the complex) indicate aliased reso-
nances from arginine N3-H3 groups.
(B) Magnification of the region between 126.2 ppm and 132.4 ppm (F1) and
9.77 ppm and 10.51 ppm (F2), which is characteristic of Trp indole N
31-H31 res-
onances.
(C) Magnification of the region between 117.8 ppm and 123.7 ppm (F1) and
7.78 ppm and 8.51 ppm (F2), which is characteristic of disordered backbone
amide resonances.Structure 1Comparison of Calcium Binding in b-NRX1
and LNS Domain 2 from a-NRX1
The structure of LNS domain 2 from a-NRX1 (Sheckler et al.,
2006) revealed a Ca2+ ion bound in a position nearly identical
to that reported here for b-NRX1. However, Ca2+ is coordinated
differently in these domains (Figure 6C). Each structure reveals 6
oxygen-containing ligands, including water molecules, providing
octahedral coordination. In b-NRX1, four ligands are from the
protein itself, one from a Glu side chain of a symmetry mate,
and one water molecule. In contrast, in a-NRX1 LNS domain 2,
Ca2+ is coordinated by three protein ligands and three water
molecules.
In b-NRX1, two main chain carbonyl groups and side chains
from two residues, Asp 137 and Asn 208, coordinate the calcium
ion. Structural alignment with the a-NRX1 LNS domain 2 struc-
ture shows that the positions of main chain carbonyl ligands
Table 2. Data Collection and Refinement Statistics
b-NRX1D b-NRX2D
Data collection
Space group P212121 C2
a, b, c (A˚) 45.0, 49.1, 63.6 95.5, 97.0, 62.6
a, b, g () 90, 90, 90 90, 106.0, 90
Resolution (A˚) 1.70 (1.76-1.70) 3.00 (3.11-3.00)
Rsym 0.058 (0.193) 0.116 (0.430)
I/sI 27.3 (6.4) 6.5 (2.0)
Completeness (%) 99.5 (95.5) 98.7 (99.6)
Redundancy 6.5 (4.7) 3.3 (3.4)
Refinement
Resolution (A˚) 20-1.7 20-3.0
No. reflections 15154 10170
Rwork/Rfree 0.176/0.220 0.211/0.289
B-factors (A˚2)
All atoms 16.3 41.1
Protein 15.0 41.2
Water 26.7 35.3
Ca2+ 13.9 N/A
R.m.s deviations
Bond lengths (A˚) 0.012 0.008
Bond angles () 1.42 1.29
Ramachandran angles
% Favored 87.8 83.8
% Allowed 11.5 15.3
% Generously allowed 0.7 1.0
% Disallowed 0.0 0.0
Values in parentheses represent the highest resolution shell.
Rsym =
X
hkl
X
i
jIiðhklÞ  hIðhklÞij=
X
hkl
X
i
Ii
Rwork =
X
hkl
jjFobsðhklÞj  jFcalcðhklÞjj=
X
hkl
jFobsðhklÞj
Rfree = Rwork was calculated using 5% of the reflection data chosen
randomly and omitted from the start of refinement.6, 410–421, March 2008 ª2008 Elsevier Ltd All rights reserved 415
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Structures of b-NRX1 and b-NRX2Figure 5. Structure of D-Isoform LNS
Domains from b-NRX1 and b-NRX2
Rainbow ribbon diagrams from blue to red rep-
resenting the N to C terminus. b Strands are
numbered, and the bound Ca2+ ion in the NRX1
structure is shown as a green sphere. The
a-carbon of residue 200, the position of splice
insertion 4, is shown as a magenta sphere. An
eight-residue stretch in the b9-b10 loop of NRX2
is disordered and is indicated by a dashed
yellow line.and an Asp side chain are almost identical between the two
structures. However, the side chain from Asn 208 found in the
b-NRX1 structure has no counterpart in a-NRX1 LNS domain
2. Sequence alignments show that Asn 208 is conserved in the
LNS domains of b-NRX from Drosophila to humans, but this res-
idue is not conserved in the other LNS domains of neurexins.
Comparison of b-NRX1 and b-NRX2 Structures
The amino acid sequences of the b-NRX1 and b-NRX2 LNS do-
mains are 78% identical, and their overall structures are very
similar. The RMS difference of Ca coordinate positions is 0.98 A˚
for 157 atom pairs. RMS Ca coordinate for b-NRX1 and b-NRX2
with LNS domain 2 from a-NRX1 is larger, 1.15 and 1.18 A˚ for 151
and 140 atom pairs, respectively.
The residues that contribute Ca2+ binding side chain ligands
are conserved (as they are in the LNS domains of all b-neurex-
ins). Despite the disordered state of the Ca2+ binding region in
the b-NRX2 structure, the surface residues on this face of the
molecule are remarkably similar. The Ca2+ binding site is formed
from residues donated from the b3-b4, b5-b6, and b9-b10 loops,
and is situated on an edge of the b sandwich that also contains
elements from the b1-b2 loop. Since neurexin-neuroligin interac-
tion is strictly Ca2+-dependent, this edge of the molecule is most
likely to interact with neuroligins. Remarkably, the residues in
each of these loops—including those disordered in b-NRX2—
are identical between b-NRX1 and b-NRX2, and there is only
a single substitution in b-NRX3.
To find possible regions of functional difference, we examined
the molecular surface charge potentials of the b-NRX1 and
b-NRX2 structures (Figure 7) using the program GRASP2 (Petrey
and Honig, 2003). The surface potentials are very similar, except
that in b-NRX2 the surface of the b1-containing sheet has a large
area of negative charge potential. This is not due to the presence
of additional negatively charged side chains but to the absence
of two positively charged side chains found in b-NRX1: Lys 147
and Lys 151.
DISCUSSION
The data presented in this article supports prior studies that sug-
gest a mechanism for Ca2+-dependent ligand recognition for
neurexins. Prior mutagenesis data implicates the Ca2+ binding416 Structure 16, 410–421, March 2008 ª2008 Elsevier Ltd All rightssite of neurexin LNS domains in binding their ligands. b-NRX1
loses its ability to bind neuroligin (Graf et al., 2006), and
a-NRX1LNSdomain 2 cannot bind dystroglycanwhen the residue
corresponding to Asp 137 is mutated (Sugita et al., 2001). The
b-NRX1 ectododmain crystal structure presented here shows
that Ca2+ is coordinated incompletely by b-NRX1, leaving open
liganding positions that can be occupied by functional groups
donated from a partner molecule. In the b-NRX1 structure, such
an ‘‘extra’’ ligand is fortuitously donated by a Glu side chain
from a symmetry-related b-NRX1 protomer. This suggests that
neuroligins and other NRX ligands may bind similarly by sharing
Ca2+ coordination with NRX. This mode of interaction is reminis-
cent of adhesive binding in integrins through their MIDAS motif
(Lee et al., 1995). The magnesium ions bound at the MIDAS sites
of integrins exhibit octahedral coordination, which is common
for magnesium centers. In contrast, although Ca2+ ions are some-
times found in octahedral geometry, it is more common that they
adopt pentagonal bipyramid coordination (Nakayama and Kret-
singer, 1994). How octahedral calcium coordination is important
for NRX ligand binding characteristics is not yet clear. Other
than their common coordination of an ‘‘extra’’ Glu ligand to com-
plete the metal coordination sphere, the NRX and integrin MIDAS
sites are structurally dissimilar.
Ca2+ binding in the neuroligin-binding b-NRX LNS domains
differs from that found for the dystroglycan-binding LNS domain
2 from a-NRX. Although the Ca2+ ions are bound at essentially
identical positions within each domain, the coordination chemis-
try differs. Interestingly, in both structures, Ca2+ is coordinated
by NRX in an octahedral geometry rather than the more common
pentagonal bipyramid coordination found for many proteins, in-
cluding those of the EF-hand and cadherin families (Nakayama
and Kretsinger, 1994). b-NRX donates 4 ligands: 2 carbonyl
oxygen atoms and side chain oxygen atoms from the b-NRX
conserved side chains Asp 137 and Asn 208. In contrast, LNS
domain 2 from a-NRX donates only three ligands, because Asn
208 is replaced by a Ser in this protein and does not partake in
Ca2+ ligation. The more complete coordination of Ca2+ in
b-NRX may imbue greater binding affinity for the ion and also
may alter binding specificity for partner proteins.
Because the b-NRXCa2+ binding surface is strongly implicated
in binding to neuroligins, it is remarkable that the residues
that make up this edge of the LNS domain, which includesreserved
Structure
Structures of b-NRX1 and b-NRX2contributions from the b1-b2, b3-b4, b5-b6, and b9-b10 loops,
are essentially identical in neurexins 1, 2, and3 (Figure 8). Promis-
cuous binding between the various b-NRX and NLs can thus be
understood through the near identity of the b-NRX at their likely
neuroligin binding surface. Whether other b-NRX regions partic-
ipate in binding is now unclear and must await determination of
Figure 6. Structure of the Ca2+ Binding Region from b-NRX1, and
Comparison with LNS2 from a-NRX1
(A) Image of 1.7 A˚ 2Fo-Fc electron density contoured at 1.0 s in the region of the
Ca2+ binding site.
(B) The Ca2+ ion is ligated by four ligands in the Ca2+ binding site, one water
molecule, and a glutamic acid side chain from a symmetry mate.
(C) Superposition of LNS2 from a-NRX1 (blue) on the b-NRX1 structure (green
and yellow) shows that the Ca2+ binding sites are positioned identically in each
LNS domain. Ligation by the N208 side chain appears to be common to all the
b-NRX but absent from many other LNS domains of a-NRX.Structurecomplex structures. Although clear differences in the b-NRX1
and b-NRX2 ectodomain structures are apparent (e.g., the large
negative surface on the b1-containing sheet unique to b-NRX2),
the functional significance of these differences is not yet clear.
The SPR binding data presented here show that the presence
of splice insertion sequence 4 in b-NRX1 has a moderate (ap-
proximately three-fold) inhibitory effect on interactions with
both NL1A and NL2A. This moderate weakening of interaction
is consistent with the idea that splice insertion sequence 4 may
introduce steric hindrance to the b-NRX/NL interaction, which
would not necessarily be revealed in the semiquantitative assay
systems employed in previous studies (Boucard et al., 2005;
Chih et al., 2006; Graf et al., 2006). Although quantitative binding
measurements have not yet been performed, prior reports sug-
gest that binding between b-NRX1+4 and NL1B is much weaker
than binding between b-NRX1D and NL1B or binding between
b-NRX1+4 and other neuroligins (Boucard et al., 2005; Chih
et al., 2006; Graf et al., 2006). This more severe reduction in bind-
ing affinity depends on the presence of glycosylation in theNL1B
insertion sequence. The carbohydrate dependence suggests
that the primary mechanism that limits interactions with NL1B
involves steric hindrance, similar to b-NRX1+4 interactions with
NL1A and NL2A. Notably, the NRX splice insertion 4 does not
contain glycosylation sites, but the amino acid sequence is
highly conserved between species. This high sequence conser-
vation seems at odds with a role solely in steric hindrance, which
would not be expected to provide strong evolutionary con-
straints on sequence. Moreover, the NMR data presented here
show that the splice site 4 insertion sequence fails to adopt an
ordered structure even in the b-NRX1+4/NL1A complex. This
disordered conformation and the high level of sequence conser-
vation suggest that splice insertion 4may play another functional
role, perhaps in recruiting binding partners other than neuroli-
gins, to the synapse.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Based on the crystal structure from Rudenko et al. (1999), we produced
expression constructs corresponding to the ordered part of the extracellular
domains for rat b-NRX1 (residues 86–288) and b-NRX2 (residues 87–290).
These regions were cloned into the pGEX6p-1 vector (GE Healthcare, Piscat-
away, NJ) to produce an N-terminal GST fusion. Protein was produced by
overexpression in E. coli BL21 cells grown at 37C and induced with IPTG.
Cells were sonicated in lysis buffer (150 mM NaCl, 20 mM Tris [pH 8], 2 mM
EDTA, 1 mM DTT, 1 mM TCEP, and 100 ng/ml leupeptin) followed by centrifu-
gation at 25,000 3 g for 1 hr at 4C. After centrifugation, the supernatant was
passed over a glutathione Sepharose affinity column. Fusion proteins were
eluted from the column with 20 mM reduced glutathione in lysis buffer. The
GST tags were removed via incubation with PreScission protease (GE Health-
care) during dialysis at 4C overnight (150 mM NaCl, 10 mM Tris [pH 8], 3 mM
CaCl2, and 1 mM DTT). Subsequently, the samples were passed over a Mono
Q column (GE Healthcare) equilibrated in 150mMNaCl, 10mMTris [pH 8], and
3mMCaCl2. The flow-through was applied to a Superdex S75 column. For the
purification of b-NRX2D, the lysis buffer contained 0.1% (v/v) Triton X-100.
Samples for NMR studies were produced as above, except that E. coli were
grown in M9 minimal medium (Sambrook et al., 2001) prepared with 15NH4Cl
(Cambridge Isotope Laboratories, Andover, MA).
Neuroligin 1A was produced using a mammalian cell expression system
based on a pCEP4 vector obtained from Invitrogen (Carlsbad, CA). pCEP4
contains the gene coding for the Epstein Barr nuclear antigen (EBNA) as well
as the EBNA replication start site. This combination allows for the episomal16, 410–421, March 2008 ª2008 Elsevier Ltd All rights reserved 417
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Structures of b-NRX1 and b-NRX2Figure 7. Comparison of Electrostatic Surface Potential in b-NRX1 and b-NRX2
Surface potentials calculated using the program GRASP2 (Petrey and Honig, 2003) are displayed in blue (positive) and red (negative) for the potential range +5 to
5 kT. The ‘‘top’’ surface is not shown for b-NRX2, because eight residues in the b9-b10 loop that contribute to the top surface are disordered.replication of the plasmid. We produced pCEP4-based expression constructs
encoding the NL1A ectodomain fused to a C-terminal 83Histidine affinity tag.
The expression vector encodes the cDNA for residues 1–612 corresponding to
the AChE-like region of the maturely spliced ectodomain, including the native
NL1 signal sequence. Stably transformed neuroligin-expressing HEK293 cells
were cultured in 10-layer cell farms (each of which yields 2 l of conditionedme-
dium). Secreted neuroligin ectodomains were purified by Ni2+ affinity chroma-
tography followed by ion exchange and gel filtration steps. Briefly, conditioned
medium was collected and brought to final concentrations of 500 mM NaCl,
20mMTris (pH 8), 20mM imidazole, and 3mMCaCl2. Themediumwas filtered
through a 0.22 mmfilter and passed over HisTrap HP columns (GE Healthcare).
The columns were washed with 500 mM NaCl, 20 mM Tris (pH 8), 20 mM im-
idazole, and 3 mM CaCl2, and the protein was eluted with 500 mM NaCl,
20 mM Tris (pH 8), 250 mM imidazole, and 3 mM CaCl2. The eluate was dia-
lyzed against 100mMNaCl, 20mMBis-Tris (pH6), and 3mMCaCl2 at 4
Cover-
night and then applied to aMonoS column (GEHealthcare) equilibratedwith the
same buffer. The flow-through was passed over a Mono Q column equilibrated
with the same buffer and eluted with a linear gradient at approximately 275mM
NaCl. Finally, the protein was subjected to size exclusion chromatography
(Superdex 200) in 150 mM NaCl, 10 mM Tris (pH 8), and 3 mM CaCl2.
Analytical Ultracentrifugation
Sedimentation velocity experiments were performed using a Beckman XL-I
ultracentrifuge in the absorption mode with an An60 Ti rotor equipped with418 Structure 16, 410–421, March 2008 ª2008 Elsevier Ltd All rightstwo-channel cells with sapphire windows. All measurements were performed
in a buffer containing 10 mM Tris-Cl (pH 8), 150 mM NaCl, and 3 mM CaCl2.
Three independent experiments were performed: b-NRX1+4 in isolation at
35 mM; NL1A in isolation at 11 mM; and a b-NRX1+4/NL1A mixture composed
of 18 mM b-NRX1+4 and 6 mM NL1A, yielding a 3:1 NRX/NL molar ratio. Be-
cause each NL dimer is expected to bind two NRX molecules, this constitutes
a molar excess of NRX. Samples were spun at 5000 rpm for 16 hr at 25C, and
scans were collected every 2 min. Concentration profile time-derivative anal-
ysis was used to determine molecular masses using SedAnal v4.78 (Walter
Stafford and Peter Sherwood, http://www.bbri.org/AUCRL.html).
SPR Binding Analysis
Binding assays were performed using a Biacore T100 biosensor equippedwith
a Series S NTA sensor chip (GE Healthcare). Neuroligins were coupled over in-
dependent flow cells using a covalent immobilization approach (Willard and
Siderovski, 2006) at 25C in HBS running buffer (10 mM HEPES [pH 7.4],
150 mM NaCl). The flow cell of interest was charged using a 60 s pulse of
500 mMof NiSO4 at 20 ml/min. The surfacewas activated using a 7min injection
of 50 mM N-hydroxysuccinimide/200 mM 1-ethyl-3(3-dimethylaminopropyl)-
carbodiimide hydrochloride (Sigma-Aldrich, St. Louis, MO) at the same flow
rate. NL1A at 16 mg/ml was injected over the activated surface at 20 ml/min.
Any remaining activated groups were blocked using a 4 min injection of
1.0 M ethanolamine (pH 8.5) (Sigma-Aldrich) at 20 ml/min. NiSO4 was removed
from the surface using five 10 s injections of 350 mM EDTA at 100 ml/min.reserved
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Structures of b-NRX1 and b-NRX2Figure 8. Sequence Alignment of the LNS Domains from Rat b-NRX1, 2, and 3 and the Ectodomains from Drosophila and Caenorhabditis
elegans Neurexins
The secondary structure of b-NRX1 is shown above the alignment. Residues that ligate Ca2+ are denoted as blue stars (side chain ligation) or circles (main chain
carbonyl ligation). The position of splice site 4 is indicated. The loop regions that contribute to the Ca2+ binding face of the b-NRX are highlighted in blue. The
disordered region of the b-NRX2 structure is highlighted in gray.The levels of immobilized NL1A and NL2A ranged between 500-700 RU. Flow
cell 2 remained unmodified to serve as a reference flow cell.
Equilibrium binding analysis was performed at 25C in a running buffer of
10mMTris-HCl (pH 7.4), 150mMNaCl, 3mMCaCl2, 0.005% (v/v) P20 supple-
mented with 0.5 mg/ml BSA for b-NRX1D, and 1 mg/ml BSA for b-NRX1+4
binding experiments. The concentrations of each neurexin tested for binding
are shown in Figure 2. Neurexin concentrations were prepared in running
buffer using a 2-fold dilution series. Samples were injected in order of increas-
ing concentration with each concentration tested for binding in triplicate. Each
sample was flowed over the neuroligin-immobilized surfaces for 60 s at a flow
rate of 50 ml/min, followed by a 60 s dissociation phase. Running buffer was
injected for 60 s at 50 ml/min at the end of each cycle to minimize sample
carry-over into the next injection. Buffer blanks were injected throughout the
experiment for double referencing (Myszka, 1999).
Data analysis was performed using Scrubber 2.0 (BioLogic Software, Pty.,
Campbell, Australia). At equilibrium, the responses were plotted against the
neurexin concentrations and fit to a 1:1 binding model to calculate the KD.
Crystallographic Analysis
We used a Mosquito crystallization robot (TTP LabTech, Cambridge, MA) to
screen through commercially prepared sets of crystallization reagents. We
found crystallization ‘‘hits’’ for each of the neurexins lacking splice insertion
sequences: b-NRX1D, b-NRX2D, and b-NRX3D. Despite extensive screening
(at least 1000 conditions for each protein at both 4C and 20C), no crystals
could be obtained for any of the neurexins that included a splice insertion se-
quence. Optimized crystals of b-NRX1Dwere obtained in 0.1MTris-Cl (pH 9.0)
and 18% PEG 8000. These crystals belonged to space group P212121 with a =
45.0, b = 49.1, and c = 63.6 A˚; had one molecule per asymmetric unit; and dif-
fracted X-rays to 1.7 A˚ resolution. The crystals were cryoprotected for freezing
in liquid nitrogen in mother liquor supplemented with 35% sucrose. Optimized
crystals of b-NRX2D were obtained in 15% PEG 4000, 0.2 M (NH4)2SO4, and
0.1 M sodium acetate (pH 4.6). These crystals were in space group C2 with
a = 95.5, b = 97.0, c = 62.6 A˚, and b = 106.0; have three molecules per asym-Structuremetric unit; and diffract X-rays to 3.0 A˚ resolution. The crystals were cryopro-
tected for freezing in liquid nitrogen in mother liquor supplemented with 35%
glycerol.
The b-NRX1D structure was determined via molecular replacement using
PDB structure 1C4R as a search model. The final structure, refined at 1.7 A˚ us-
ing CNS (Brunger et al., 1998) and Refmac (CCP4, 1994) resolution (R = 0.176,
Rfree = 0.220), had one molecule per asymmetric unit, 1481 protein atoms, 188
water molecules, and one Ca2+ ion bound per neurexin protomer. Using this
structure as a search model, we determined the structure of b-NRX2D at
3.0 A˚ resolution (R = 0.211, Rfree = 0.289). (Because of the limited resolution,
this model included no water molecules.) Noncrystallographic symmetry
restraints were used in the initial stages of refinement for b-NRX2D but were
removed for the final few rounds of refinement. Crystallographic statistics
are shown in Table 2.
NMR Spectroscopy
Samples for NMR spectroscopy were 0.6 mM b-NRX1D or b-NRX1+4 for the
spectra of the uncomplexed neurexins, and 0.25 mM b-NRX1+4 with
0.27 mM NL1A for the spectrum of the complex 10% D2O/90% H2O, 10 mM
Bis-Tris, 150 mM NaCl, and 3 mM CaCl2 (pH 6.5). An excess of NL1A was
used to ensure that all b-NRX1 molecules would be bound to NL1A partners.
All spectra of the uncomplexed neurexinswere recorded at 300K using aBruker
DRX600NMRspectrometer (ColumbiaUniversity, NewYork, NY) equippedwith
a triple-resonance Z-axis gradient cryoprobe. The FHSQC spectrum of the
complex was recorded using an Avance800 NMR spectrometer (New York
Structural Biology Center, New York, NY) equipped with a triple-resonance
Z-axisgradient cryoprobe. Two-dimensional FHSQCspectra of the uncomplexed
neurexins were recorded using 256 3 512 complex t1 3 t2 points and spectral
widths of 30003 8993 Hz in F13 F2; ZZ-exchange spectra of the uncomplexed
neurexins were recorded using 256 3 512 complex t1 3 t2 points and spectral
widths of 30413 8993 Hz in F13 F2; and {
1H}-15N NOE spectra of the uncom-
plexed neurexins were recorded using 512 3 512 complex t1 3 t2 points
and spectral widths of 3000 3 8993 Hz in F1 3 F2. The FHSQC spectrum of16, 410–421, March 2008 ª2008 Elsevier Ltd All rights reserved 419
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Structures of b-NRX1 and b-NRX2the b-NRX1+4/NL complex was recorded using 384 3 1024 complex t1 3 t2
points and a spectral width of 3,333 3 14,006 Hz. FHSQC (Mori et al., 1995),
ZZ-exchange (Farrow et al., 1994b), and {1H}-15N NOE (Farrow et al., 1994a)
spectra were recorded using standard pulse sequences. The mixing times for
the ZZ-exchange experiment were 0.01, 0.5, and 1.0 s. The {1H}-15N NOE ex-
periment used a 1H saturation timeof 3 s and a recycle delay of 3 s for the control
spectrum. The steady-state NOE was calculated as the ratio of the intensity of
the saturated spectrum to the intensity of the control (unsaturated) spectrum. All
spectra were processed using NMRpipe (Delaglio et al., 1995) and analyzed us-
ing Sparky (T.D. Goddard, and D.G. Kneller, SPARKY 3, University of California,
San Francisco, CA).
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